06Jan

Overcoming the Limitations of Mass Spectrometry Across Datasets

January 6, 2022 Metabolon 105

Metabolon implemented solutions to overcome some of the limitations of MS-based metabolomics while maximizing longitudinal reproducibility. At Metabolon, we implemented solutions based on data normalization and quality control (QC) as critical data processing components to improve data quality and reduce the non-biological variation in the samples. These solutions allow us to overcome some of the limitations of MS-based metabolomics while maximizing longitudinal reproducibility.

01Sep

Metabolomics Drives Identification of Rare Disease Signatures and Diagnoses

September 1, 2021 Metabolon 112

Rare diseases represent a unique challenge in clinical medicine. These diseases signify that few people have these diseases and even fewer have a successful diagnosis. Rare diseases are classified in many categories, including metabolic diseases, rare cancers, autoimmune diseases, blood disorders, digestive diseases, endocrine system disorders, nervous system diseases, reproductive disorders, and musculoskeletal diseases.

20May

Evaluating Metabolite Stability of Blood Samples for Clinical Applications

May 20, 2021 Metabolon 116

Metabolon’s extensive work establishes criteria for evaluating metabolite stability in clinical metabolomic applications and provides guidelines for disqualifying unstable metabolites deriving from sample handling and processing in clinical metabolomic studies to ensure pre-analytical compliance.

28Apr

Metabolomics and Shotgun Metagenomics Reveal Evidence That Glyphosate Exposure Affects the Gut Microbiome

April 28, 2021 Metabolon 124

A multi-omics approach provides valuable insights for investigating complex areas of science to enhance our understanding while Metabolon’s platform delivers interpretive depth not possible elsewhere. Additionally, the profiling of multiple matrices allowed for analysis of both microbiome derived compounds as well as how those changes may be reflected systemically, giving the work a much broader impact.

27Apr

Metabolon’s Validation of Dried Blood Spot (DBS) Cards for Metabolomics Analysis

April 27, 2021 Metabolon 118

DBS is a valuable and convenient sampling option to drive metabolomics research forward. In this Q&A section, we asked Kelli Goodman, Staff Scientist at Metabolon, to address some of the common questions regarding the use of DBS samples for metabolomics analysis.

29Oct

Metabolon’s Client Data Table Enables Study Analysis

October 29, 2020 MetabolonDesign 157

Metabolon’s newly updated Client Data Table format helps clients review, analyze and understand their project data while making it easier to import into statistical tools like R and Python.

28Oct

Establishing Industry QA/QC Best Practices for Global Metabolomics

October 28, 2020 Metabolon 156

When evaluating large quantities of information, it is paramount to make data quality a top priority. Metabolon’s Precision Metabolomics™ Data quality is extremely important to maintaining exceptionally high standards. From start to finish, Metabolon emphasizes quality control measures and checks and balances.

03Sep

3 Ways Machine Learning Propels Metabolomics at Metabolon

September 3, 2020 MetabolonDesign 154

At Metabolon, we have spent the last 20 years building the best metabolomic competency in the world. Today, we enable, accelerate, and support drug development through biomarker discovery, understanding mechanism of action, patient stratification and more. One tool we use to power our work is machine learning, which automates routine tasks and teachable processes so our experts can focus their efforts on the challenges that most require their expertise.

18Aug

Metabolon and DNA Genotek: Collaborating to Advance Functional Understanding of the Microbiome

August 18, 2020 MetabolonDesign 164

Metabolomic data can play a pivotal role in understanding critical questions across the life sciences—the launch of DNA Genotek’s OMNImet.GUT validated by Metabolon dramatically expanded the accessibility of metabolomics for gut microbiome studies. This milestone shows how Metabolon can deliver innovative metabolomic insights through other collaborations.

17Jun

For a Successful Metabolomics Study, Don’t Risk Going it Alone

June 17, 2020 Metabolon 153

A successful metabolomics study requires a comprehensive approach focused on quality and accuracy. That's why choosing the right partner can yield many more insights than trying to go it on your own, all while avoiding expensive mistakes. Consider these four risks that come with trying to do a metabolomics analysis without support.